封面
市场调查报告书
商品编码
1378570

米诺地尔市场:依类型、给药途径、性别、配销通路、地区

Minoxidil Market, By Type, By Route of Administration, By Gender, By Distribution Channel, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 210 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年全球米诺地尔市场规模为10.955亿美元,预测期内(2023-2030年)年复合成长率为4.8%。

报告范围 报告详情
基准年 2022年 2023年市场规模 10.955 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 4.80% 2030年市场规模预测 15.211 亿美元
图 1. 米诺地尔全球市场占有率(%)(按类型),2023 年
米诺地尔市场-IMG1

米诺地尔是一种用于治疗高血压和脱髮的药物。它是一种抗高血压血管扩张剂。它可以作为非专利药物、透过处方笺作为口服锭剂、以及在非处方商店中作为局部溶液或泡沫。米诺地尔是一种外用抗高血压药,可促进头髮生长。米诺地尔主要用于治疗雄性脱髮症,也用作其他脱髮症仿单标示外的标籤外治疗。米诺地尔是美国食品药物管理局(FDA)核准的2%米诺地尔溶液,于1986年首次推向市场,1993年推出5%溶液。

市场动态

主要市场参与者越来越多地采用内部成长策略,例如推出产品以扩大产品系列,预计将在预测期内推动市场成长。例如,2020年11月,美国最大的毛髮再生公司Bosley推出了BosleyRx,这是一种针对男性的处方脱髮药物的现代方法。透过简单的线上流程,经验丰富的医疗专业人员可以诊断并开立预防脱髮和头髮生长治疗的处方。

本研究的主要特点

  • 本报告对全球米诺地尔市场进行了详细分析,并提出了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR)。
  • 它还强调了各个细分市场的潜在收益成长机会,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数,介绍了全球米诺地尔市场的主要企业。
  • 本研究涵盖的主要企业包括辉瑞公司、Atom pharma、Perrigo Company plc、Johnson and Johnson Services, Inc.、Merck KGaA、Actavis Pharma, Inc.、Apotex Inc.、UltiMed Inc.、DS LABORATORIES, INC.、Taisho Pharmaceutical Co., Ltd.、NIKSAN PHARMACEUTICAL、SALVAVIDAS PHARMACEUTICAL PVT.Ltd.、Maruti Futuristic Pharma Pvt.Ltd.、Sun Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Lupin、Steris Healthcare PVT Ltd.、Salvus Pvt Ltd.、Par Pharmaceutical、QndQ Derma。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 米诺地尔全球市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过分析全球米诺地尔市场时所使用的各种策略矩阵来促进决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最近测试启动
  • 流行病学
  • 合併、收购和合作
  • 监管场景
  • 主要进展
  • PEST分析

第4章全球米诺地尔市场 - COVID-19感染疾病的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 对需求和供给的影响

第5章全球米诺地尔市场,依类型,2018-2030

  • 5%米诺地尔
  • 2%米诺地尔

第6章全球米诺地尔市场,依给药途径,2018-2030

  • 口服
  • 外用

第7章全球米诺地尔市场,依性别,2018-2030

  • 男性
  • 女士

第8章全球米诺地尔市场,依配销通路划分,2018-2030

  • 医院药房
  • 零售药房
  • 线上药房

第9章全球米诺地尔市场,按地区,2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI4375

The global minoxidil market is estimated to be valued at US$ 1,095.5 million in 2023 and is expected to exhibit a CAGR of 4.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,095.5 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.80% 2030 Value Projection: US$ 1,521.1 Mn
Figure 1. Global Minoxidil Market Share (%), By Type, 2023
Minoxidil Market - IMG1

Minoxidil is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive vasodilator. It is available as a generic medication by prescription in the oral tablet form and over-the-counter as a topical liquid or foam. Minoxidil, an antihypertensive topical formulation, promotes hair growth. Minoxidil is majorly prescribed for the treatment of androgenetic alopecia, and it is also used as an off-label treatment for other hair loss conditions. Minoxidil is a U.S. Food and Drug Administration (FDA) approved, 2% minoxidil solution and was first launched in the market in 1986, followed by the 5% solution in 1993, and it is majorly applicable in hair growth promotion.

Market Dynamics

The increasing adoption of organic growth strategies, such as product launches, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in November 2020, Bosley, the largest hair restoration company in the U.S., launched BosleyRx, the modern-day approach to prescription hair loss medications for men. Through a simple online process, an experienced medical professional can diagnose and prescribe hair loss prevention and growth treatments.

Key features of the study:

  • This report provides an in-depth analysis of the global minoxidil market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global minoxidil market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Pfizer Inc., Atom pharma, Perrigo Company plc, Johnson and Johnson Services, Inc., Merck KGaA, Actavis Pharma, Inc., Apotex Inc., UltiMed Inc., DS LABORATORIES, INC., Taisho Pharmaceutical Co., Ltd., NIKSAN PHARMACEUTICAL, SALVAVIDAS PHARMACEUTICAL PVT. LTD., Maruti Futuristic Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin, Steris Healthcare PVT Ltd, Salvus Pharma, Unison Pharmaceuticals Pvt Ltd, Par Pharmaceutical, and QndQ Derma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market

Global Minoxidil Market Detailed Segmentation:

  • By Type:
    • 5% Minoxidil
    • 2% Minoxidil
  • By Route of Administration:
    • Oral
    • Topical
  • By Gender:
    • Male
    • Female
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Gender
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Minoxidil Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Minoxidil Market, By Type, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • 5% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • 2% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Minoxidil Market, By Route of Administration, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Minoxidil Market, By Gender, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Minoxidil Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

9. Global Minoxidil Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact